FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955102470> ?p ?o ?g. }

• W2955102470 abstract "Abstract Background Volasertib induces mitotic arrest and apoptosis by targeting Polo‐like kinases. In this phase I dose‐escalation study, the maximum tolerated dose (MTD), pharmacokinetics (PK), and preliminary efficacy of volasertib were determined in pediatric patients. Methods Patients aged 2 to <18 years with relapsed/refractory acute leukemia/advanced solid tumors (ST) without available effective treatments were enrolled—cohort C1 (aged 2 to <12 years); cohort C2 (aged 12 to <18 years). The patients received volasertib intravenously (starting dose: 200 mg/m 2 body surface area on day 1, every 14 days). The primary endpoint was the pediatric MTD for further development. Results Twenty‐two patients received treatment (C1: leukemia, n = 4; ST, n = 8; C2: leukemia, n = 3; ST, n = 7). No dose‐limiting toxicities (DLTs) occurred up to 300 mg/m 2 volasertib in C1; two patients in C2, at 250 mg/m 2 volasertib, had DLTs in cycle 1, one of which led to death; therefore, the MTD of volasertib in C2 was 200 mg/m 2 . The most common grade 3/4 adverse events (all patients) were febrile neutropenia, thrombocytopenia, and neutropenia (41% each). Stable disease (SD) was the best objective response (leukemia, n = 5; ST, n = 2); the duration of SD was short in all patients, except in one with an ST. PK profiles were generally comparable across dose groups and were consistent with those in adults. Conclusion The pediatric MTD/dose for further development was identified. There were no unexpected safety or PK findings; limited antitumor/antileukemic activity was demonstrated." @default.
• W2955102470 created "2019-07-12" @default.
• W2955102470 creator A5011992727 @default.
• W2955102470 creator A5022712318 @default.
• W2955102470 creator A5033870647 @default.
• W2955102470 creator A5037934940 @default.
• W2955102470 creator A5061831442 @default.
• W2955102470 creator A5062188329 @default.
• W2955102470 creator A5063120070 @default.
• W2955102470 creator A5070769057 @default.
• W2955102470 creator A5071534196 @default.
• W2955102470 creator A5076074059 @default.
• W2955102470 creator A5076502958 @default.
• W2955102470 creator A5077232595 @default.
• W2955102470 creator A5077603727 @default.
• W2955102470 date "2019-07-05" @default.
• W2955102470 modified "2023-10-01" @default.
• W2955102470 title "Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors" @default.
• W2955102470 cites W1487327361 @default.
• W2955102470 cites W1557877432 @default.
• W2955102470 cites W1558704041 @default.
• W2955102470 cites W1951421707 @default.
• W2955102470 cites W1973908775 @default.
• W2955102470 cites W1982304115 @default.
• W2955102470 cites W2019607817 @default.
• W2955102470 cites W2021246859 @default.
• W2955102470 cites W2021663709 @default.
• W2955102470 cites W2022538460 @default.
• W2955102470 cites W2023678160 @default.
• W2955102470 cites W2029108033 @default.
• W2955102470 cites W2058153393 @default.
• W2955102470 cites W2074245850 @default.
• W2955102470 cites W2078025015 @default.
• W2955102470 cites W2080849052 @default.
• W2955102470 cites W2101440707 @default.
• W2955102470 cites W2101725260 @default.
• W2955102470 cites W2114135705 @default.
• W2955102470 cites W2124670745 @default.
• W2955102470 cites W2127019295 @default.
• W2955102470 cites W2134118606 @default.
• W2955102470 cites W2158094911 @default.
• W2955102470 cites W2167831982 @default.
• W2955102470 cites W2168541390 @default.
• W2955102470 cites W2235393999 @default.
• W2955102470 cites W2333597938 @default.
• W2955102470 cites W2549761003 @default.
• W2955102470 cites W2690406299 @default.
• W2955102470 cites W2806061299 @default.
• W2955102470 cites W2979393870 @default.
• W2955102470 cites W749488837 @default.
• W2955102470 doi "https://doi.org/10.1002/pbc.27900" @default.
• W2955102470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31276318" @default.
• W2955102470 hasPublicationYear "2019" @default.
• W2955102470 type Work @default.
• W2955102470 sameAs 2955102470 @default.
• W2955102470 citedByCount "3" @default.
• W2955102470 countsByYear W29551024702019 @default.
• W2955102470 countsByYear W29551024702022 @default.
• W2955102470 crossrefType "journal-article" @default.
• W2955102470 hasAuthorship W2955102470A5011992727 @default.
• W2955102470 hasAuthorship W2955102470A5022712318 @default.
• W2955102470 hasAuthorship W2955102470A5033870647 @default.
• W2955102470 hasAuthorship W2955102470A5037934940 @default.
• W2955102470 hasAuthorship W2955102470A5061831442 @default.
• W2955102470 hasAuthorship W2955102470A5062188329 @default.
• W2955102470 hasAuthorship W2955102470A5063120070 @default.
• W2955102470 hasAuthorship W2955102470A5070769057 @default.
• W2955102470 hasAuthorship W2955102470A5071534196 @default.
• W2955102470 hasAuthorship W2955102470A5076074059 @default.
• W2955102470 hasAuthorship W2955102470A5076502958 @default.
• W2955102470 hasAuthorship W2955102470A5077232595 @default.
• W2955102470 hasAuthorship W2955102470A5077603727 @default.
• W2955102470 hasBestOaLocation W29551024701 @default.
• W2955102470 hasConcept C121332964 @default.
• W2955102470 hasConcept C126322002 @default.
• W2955102470 hasConcept C142424586 @default.
• W2955102470 hasConcept C143998085 @default.
• W2955102470 hasConcept C197934379 @default.
• W2955102470 hasConcept C203092338 @default.
• W2955102470 hasConcept C2776694085 @default.
• W2955102470 hasConcept C2777063308 @default.
• W2955102470 hasConcept C2778461978 @default.
• W2955102470 hasConcept C2778850193 @default.
• W2955102470 hasConcept C535046627 @default.
• W2955102470 hasConcept C71924100 @default.
• W2955102470 hasConcept C72563966 @default.
• W2955102470 hasConcept C87355193 @default.
• W2955102470 hasConceptScore W2955102470C121332964 @default.
• W2955102470 hasConceptScore W2955102470C126322002 @default.
• W2955102470 hasConceptScore W2955102470C142424586 @default.
• W2955102470 hasConceptScore W2955102470C143998085 @default.
• W2955102470 hasConceptScore W2955102470C197934379 @default.
• W2955102470 hasConceptScore W2955102470C203092338 @default.
• W2955102470 hasConceptScore W2955102470C2776694085 @default.
• W2955102470 hasConceptScore W2955102470C2777063308 @default.
• W2955102470 hasConceptScore W2955102470C2778461978 @default.
• W2955102470 hasConceptScore W2955102470C2778850193 @default.
• W2955102470 hasConceptScore W2955102470C535046627 @default.
• W2955102470 hasConceptScore W2955102470C71924100 @default.
• W2955102470 hasConceptScore W2955102470C72563966 @default.

• next